folder_name,note_name,question,best_answer,correct_answer,ai_answer,note_answer,ai_word_count,note_word_count
note2,AI.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI.txt,What procedure is scheduled for November 2024 to manage the patient's chronic pain?,Neurolytic celiac plexus block,Neurolytic celiac plexus block,Neurolytic celiac plexus block,Neurolytic celiac plexus block,432,432
note2,AI.txt,Which antibiotic is part of the patient's current intravenous treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,432
note2,AI.txt,What imaging modality is planned for follow-up of the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI.txt,"What surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,432
note2,AI.txt,What condition related to bone density does the patient have a history of?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,432
note2,AI.txt,"What type of abdominal issue was identified via imaging during the patient's ER admission on January 24, 2024?",Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,432,432
note2,AI.txt,What type of infections are confirmed via imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,432
note2,AI.txt,What is the patient's current surgical consultation focus?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,432
note2,AI.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,432
note2,AI.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI.txt,"What surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,432
note2,AI.txt,What chronic renal condition does the patient have?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,432
note2,AI.txt,"What imaging finding was noted during the patient's ER admission on January 24, 2024?",Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,432,432
note2,AI.txt,What type of imaging is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI.txt,What type of cancer care is the patient transitioning to?,Adult oncology,Adult oncology,Adult oncology,Adult oncology,432,432
note2,AI.txt,What is the main goal of the patient's palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,432
note2,AI.txt,What is the primary genetic condition affecting the patient in the medical note?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI.txt,"What surgical procedure was performed on September 21, 2023, for bowel obstruction?",Exploratory Laparotomy with Adhesiolysis,Exploratory Laparotomy with Adhesiolysis,Exploratory Laparotomy with Adhesiolysis,Exploratory Laparotomy with Adhesiolysis,432,432
note2,AI.txt,Which imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI.txt,Which surgical procedure did the patient undergo in September 2023?,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,432
note2,AI.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI.txt,What type of care services is the patient currently managed by?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,432
note2,AI.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,432
note2,AI.txt,What surgical procedure has been deferred for the patient?,Invasive biopsy of abdominal collections,Invasive biopsy of abdominal collections,Invasive biopsy of abdominal collections,Invasive biopsy of abdominal collections,432,432
note2,AI.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,432
note2,AI.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI.txt,Which condition related to bone density has been confirmed by DEXA scans?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,432
note2,AI.txt,What is the primary focus of the patient's current palliative care?,Management of chronic visceral abdominal pain,Management of chronic visceral abdominal pain,Management of chronic visceral abdominal pain,Management of chronic visceral abdominal pain,432,432
note2,AI.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,432
note2,AI.txt,What surgical consultation is planned for the patient?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,432
note2,AI.txt,What is the planned follow-up care for potential malignancy of hepatic lesions?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,432
note2,AI.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,432
note2,AI.txt,What postoperative treatment did the patient receive after the excision of the MPNST?,External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),432,432
note2,AI.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,432
note2,AI.txt,What imaging is planned to evaluate the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI.txt,What is the patient's current palliative care focus?,Symptom management and quality of life improvement,Symptom management and quality of life improvement,Symptom management and quality of life improvement,Symptom management and quality of life improvement,432,432
note2,AI.txt,What is the patient's follow-up plan regarding oncology care?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,432
note2,AI_inj_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,441
note2,AI_inj_ir1.txt,Which surgical procedure did the patient undergo in September 2023?,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,441
note2,AI_inj_ir1.txt,Which antibiotic is NOT part of the patient's current intravenous treatment regimen?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,441
note2,AI_inj_ir1.txt,"What complication was identified via imaging on November 29, 2023?",Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,441
note2,AI_inj_ir1.txt,What type of imaging is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,441
note2,AI_inj_ir1.txt,Which condition is NOT part of the patient's medical history?,Diabetes mellitus,Diabetes mellitus,Diabetes mellitus,Diabetes mellitus,432,441
note2,AI_inj_ir1.txt,Which palliative care service is involved in the patient's management?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,441
note2,AI_inj_ir1.txt,What surgical procedure did the patient undergo related to urinary diversion?,Ureterostomy and ileal conduit,Ureterostomy and ileal conduit,Ureterostomy and ileal conduit,Ureterostomy and ileal conduit,432,441
note2,AI_inj_ir1.txt,What is the primary genetic condition affecting the patient in the medical report?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,441
note2,AI_inj_ir1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,441
note2,AI_inj_ir1.txt,What type of imaging is planned to evaluate the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,441
note2,AI_inj_ir1.txt,Which medications are being used for the patient's infection management?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,441
note2,AI_inj_ir1.txt,What is the primary focus of the patient's palliative care?,Chronic pain management,Chronic pain management,Chronic pain management,Chronic pain management,432,441
note2,AI_inj_ir1.txt,What is the patient's recent history regarding abdominal imaging?,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,432,441
note2,AI_inj_ir1.txt,Which surgical procedure has the patient undergone related to her urinary system?,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,432,441
note2,AI_inj_ir1.txt,What is the patient's planned follow-up care for potential malignancy?,Monitoring hepatic lesions,Monitoring hepatic lesions,Monitoring hepatic lesions,Monitoring hepatic lesions,432,441
note2,AI_inj_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,441
note2,AI_inj_ir1.txt,"Which surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,441
note2,AI_inj_ir1.txt,What imaging modality is planned for follow-up of the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,441
note2,AI_inj_ir1.txt,Which type of care services are managing the patient's chronic pain?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,441
note2,AI_inj_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,441
note2,AI_inj_ir1.txt,"What surgical procedure was performed on the patient on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,441
note2,AI_inj_ir1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,441
note2,AI_inj_ir1.txt,What imaging modality is planned to evaluate hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,441
note2,AI_inj_ir1.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,441
note2,AI_inj_ir1.txt,What type of care services is the patient currently managed by?,Both pediatric and adult palliative care services,Both pediatric and adult palliative care services,Both pediatric and adult palliative care services,Both pediatric and adult palliative care services,432,441
note2,AI_inj_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,441
note2,AI_inj_ir1.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,441
note2,AI_inj_ir1.txt,Which antibiotic is part of the patient's current intravenous treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,441
note2,AI_inj_ir1.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,441
note2,AI_inj_ir1.txt,What chronic pain management medication is the patient currently using?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,441
note2,AI_inj_ir1.txt,What condition has been confirmed by DEXA scans in the patient?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,441
note2,AI_inj_ir1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,441
note2,AI_inj_ir1.txt,What type of collections were identified via imaging during the recent admissions?,Intraperitoneal collections,Intraperitoneal collections,Intraperitoneal collections,Intraperitoneal collections,432,441
note2,AI_inj_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,441
note2,AI_inj_ir1.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,441
note2,AI_inj_ir1.txt,What imaging is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,441
note2,AI_inj_ir1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,441
note2,AI_inj_ir1.txt,Which pain management medications is the patient currently using?,Fentanyl and Methadone,Fentanyl and Methadone,Fentanyl and Methadone,Fentanyl and Methadone,432,441
note2,AI_inj_ir1.txt,What type of care is the patient receiving for chronic pain management?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,441
note2,AI_inj_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,442
note2,AI_inj_ir2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,442
note2,AI_inj_ir2.txt,Which antibiotic is part of the patient's current intravenous treatment regimen?,Meropenem,Meropenem,Meropenem,Meropenem,432,442
note2,AI_inj_ir2.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,442
note2,AI_inj_ir2.txt,Which imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,442
note2,AI_inj_ir2.txt,What chronic pain management medication is the patient currently using?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,442
note2,AI_inj_ir2.txt,What condition related to bone health does the patient have a history of?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,442
note2,AI_inj_ir2.txt,Which surgical procedure has the patient undergone for urinary diversion?,Ileal conduit,Ileal conduit,Ileal conduit,Ileal conduit,432,442
note2,AI_inj_ir2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,442
note2,AI_inj_ir2.txt,What is the patient's current status regarding adult oncology and palliative care?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,442
note2,AI_inj_ir2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,442
note2,AI_inj_ir2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,442
note2,AI_inj_ir2.txt,What condition was confirmed by DEXA scans between 2019-2021?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,442
note2,AI_inj_ir2.txt,Which antibiotic is part of the patient's current intravenous treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,442
note2,AI_inj_ir2.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,442
note2,AI_inj_ir2.txt,"What was the outcome of the January 24, 2024 ER admission?",Identification of intraperitoneal collections and hepatic lesions,Identification of intraperitoneal collections and hepatic lesions,Identification of intraperitoneal collections and hepatic lesions,Identification of intraperitoneal collections and hepatic lesions,432,442
note2,AI_inj_ir2.txt,What type of infections are confirmed via imaging?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,442
note2,AI_inj_ir2.txt,What is the planned surgical consultation for?,Abdominal collections,Abdominal collections,Abdominal collections,Abdominal collections,432,442
note2,AI_inj_ir2.txt,Which medication is used for the patient's chronic pain management?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,442
note2,AI_inj_ir2.txt,What is the patient's follow-up care plan regarding potential malignancy?,Monitoring and transition to adult oncology,Monitoring and transition to adult oncology,Monitoring and transition to adult oncology,Monitoring and transition to adult oncology,432,442
note2,AI_inj_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,442
note2,AI_inj_ir2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,442
note2,AI_inj_ir2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,442
note2,AI_inj_ir2.txt,Which medication is part of the patient's current intravenous antibiotic regimen?,Meropenem,Meropenem,Meropenem,Meropenem,432,442
note2,AI_inj_ir2.txt,What chronic condition is the patient non-compliant with treatment for?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,442
note2,AI_inj_ir2.txt,What type of care is the patient receiving for chronic pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,442
note2,AI_inj_ir2.txt,What is the patient's current antibiotic treatment for infections?,Intravenous Meropenem and Vancomycin,Intravenous Meropenem and Vancomycin,Intravenous Meropenem and Vancomycin,Intravenous Meropenem and Vancomycin,432,442
note2,AI_inj_ir2.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,442
note2,AI_inj_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,442
note2,AI_inj_ir2.txt,Which surgical procedure did the patient undergo in September 2023?,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,442
note2,AI_inj_ir2.txt,Which antibiotic is NOT part of the patient's current intravenous treatment regimen?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,442
note2,AI_inj_ir2.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,442
note2,AI_inj_ir2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,442
note2,AI_inj_ir2.txt,What chronic condition related to bone health does the patient have?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,442
note2,AI_inj_ir2.txt,Which pain management medication is the patient currently using?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,442
note2,AI_inj_ir2.txt,What type of infections are confirmed via imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,442
note2,AI_inj_ir2.txt,Which of the following is NOT part of the patient's recent admissions and clinical events?,Successful bowel resection,Successful bowel resection,Successful bowel resection,Successful bowel resection,432,442
note2,AI_inj_ir2.txt,What type of care services are managing the patient's chronic pain?,Palliative care services,Palliative care services,Palliative care services,Palliative care services,432,442
note2,AI_inj_ir2.txt,What is the patient's planned surgical consultation focus?,Abdominal collections,Abdominal collections,Abdominal collections,Abdominal collections,432,442
note2,AI_inj_ir2.txt,Which of the following is part of the patient's discharge instructions?,Follow-up imaging with PET/CT,Follow-up imaging with PET/CT,Follow-up imaging with PET/CT,Follow-up imaging with PET/CT,432,442
note2,AI_inj_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,448
note2,AI_inj_ir3.txt,What chronic renal condition is the patient experiencing?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,448
note2,AI_inj_ir3.txt,"What surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,448
note2,AI_inj_ir3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,448
note2,AI_inj_ir3.txt,What type of infections are confirmed via imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,448
note2,AI_inj_ir3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,448
note2,AI_inj_ir3.txt,What is the focus of the patient's ongoing palliative care?,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,432,448
note2,AI_inj_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,448
note2,AI_inj_ir3.txt,"Which surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,448
note2,AI_inj_ir3.txt,What is the current renal condition affecting the patient?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,448
note2,AI_inj_ir3.txt,What chronic pain management medication is the patient currently using?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,448
note2,AI_inj_ir3.txt,What imaging is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,448
note2,AI_inj_ir3.txt,What is the primary goal of the patient's current palliative care?,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,432,448
note2,AI_inj_ir3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,448
note2,AI_inj_ir3.txt,Which antibiotic is part of the patient's current intravenous treatment?,Meropenem,Meropenem,Meropenem,Meropenem,432,448
note2,AI_inj_ir3.txt,What surgical procedure was performed to address the patient's bowel obstructions?,End ileostomy,End ileostomy,End ileostomy,End ileostomy,432,448
note2,AI_inj_ir3.txt,"What type of lesions were revealed in the imaging conducted on January 24, 2024?",Hepatic lesions,Hepatic lesions,Hepatic lesions,Hepatic lesions,432,448
note2,AI_inj_ir3.txt,What type of care services is the patient managed by?,Both pediatric and adult palliative care services,Both pediatric and adult palliative care services,Both pediatric and adult palliative care services,Both pediatric and adult palliative care services,432,448
note2,AI_inj_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,448
note2,AI_inj_ir3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,448
note2,AI_inj_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,448
note2,AI_inj_ir3.txt,What chronic renal condition does the patient have?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,448
note2,AI_inj_ir3.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,448
note2,AI_inj_ir3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,448
note2,AI_inj_ir3.txt,What type of infections are confirmed by imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,448
note2,AI_inj_ir3.txt,Which antibiotic is part of the patient's current treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,448
note2,AI_inj_ir3.txt,What is the patient's follow-up plan regarding oncology care?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,448
note2,AI_inj_ir3.txt,What condition has the patient experienced that involves the gastrointestinal system?,Bowel obstructions,Bowel obstructions,Bowel obstructions,Bowel obstructions,432,448
note2,AI_inj_ir3.txt,What type of care is the patient receiving for chronic pain and quality of life improvement?,Palliative care,Palliative care,Palliative care,Palliative care,432,448
note2,AI_inj_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,448
note2,AI_inj_ir3.txt,Which surgical procedure did the patient undergo in September 2023?,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,448
note2,AI_inj_ir3.txt,What imaging modality is planned for follow-up of the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,448
note2,AI_inj_ir3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,448
note2,AI_inj_ir3.txt,What type of care is the patient receiving to manage her chronic pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,448
note2,AI_inj_ir3.txt,What condition has the patient been non-compliant with regarding treatment?,Hormone replacement therapy and vitamin D supplementation,Hormone replacement therapy and vitamin D supplementation,Hormone replacement therapy and vitamin D supplementation,Hormone replacement therapy and vitamin D supplementation,432,448
note2,AI_inj_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,448
note2,AI_inj_ir3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,448
note2,AI_inj_ir3.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,448
note2,AI_inj_ir3.txt,What chronic condition is managed with fentanyl and methadone in this patient?,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,432,448
note2,AI_inj_ir3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,448
note2,AI_inj_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,453
note2,AI_inj_ir4.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,453
note2,AI_inj_ir4.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,453
note2,AI_inj_ir4.txt,Which antibiotic is part of the patient's current intravenous treatment plan?,Meropenem,Meropenem,Meropenem,Meropenem,432,453
note2,AI_inj_ir4.txt,What imaging modality is planned to evaluate the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,453
note2,AI_inj_ir4.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,453
note2,AI_inj_ir4.txt,What type of infections are confirmed via imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,453
note2,AI_inj_ir4.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,453
note2,AI_inj_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,453
note2,AI_inj_ir4.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,453
note2,AI_inj_ir4.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,453
note2,AI_inj_ir4.txt,Which antibiotic is NOT part of the current intravenous treatment for the patient's infections?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,453
note2,AI_inj_ir4.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,453
note2,AI_inj_ir4.txt,What chronic condition related to bone health does the patient have?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,453
note2,AI_inj_ir4.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,453
note2,AI_inj_ir4.txt,What is the primary goal of the patient's ongoing palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,453
note2,AI_inj_ir4.txt,What type of lesions were identified in the patient's imaging?,Hepatic lesions,Hepatic lesions,Hepatic lesions,Hepatic lesions,432,453
note2,AI_inj_ir4.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,453
note2,AI_inj_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,453
note2,AI_inj_ir4.txt,What type of tumor did the patient have that required treatment in 2018?,Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),432,453
note2,AI_inj_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,453
note2,AI_inj_ir4.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,453
note2,AI_inj_ir4.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,453
note2,AI_inj_ir4.txt,What imaging is planned for assessing hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,453
note2,AI_inj_ir4.txt,What chronic condition is confirmed by DEXA scans in the patient?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,453
note2,AI_inj_ir4.txt,What is the patient's current antibiotic treatment?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,453
note2,AI_inj_ir4.txt,What type of surgical consultation is planned for the patient?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,453
note2,AI_inj_ir4.txt,What type of care services manage the patient's chronic pain?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,453
note2,AI_inj_ir4.txt,What is the patient's follow-up plan for potential malignancy?,Monitoring hepatic lesions,Monitoring hepatic lesions,Monitoring hepatic lesions,Monitoring hepatic lesions,432,453
note2,AI_inj_ir4.txt,What is the patient's primary genetic condition?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,453
note2,AI_inj_ir4.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,453
note2,AI_inj_ir4.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,453
note2,AI_inj_ir4.txt,Which imaging technique is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,453
note2,AI_inj_ir4.txt,What type of care is the patient receiving for chronic pain and multisystem involvement?,Palliative care,Palliative care,Palliative care,Palliative care,432,453
note2,AI_inj_ir4.txt,Which antibiotic is part of the patient's current intravenous treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,453
note2,AI_inj_ir4.txt,What type of surgical consultation is planned for the patient?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,453
note2,AI_inj_ir4.txt,What type of follow-up care is the patient transitioning to?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,453
note2,AI_inj_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,453
note2,AI_inj_ir4.txt,"What was the treatment completed on December 16, 2018, following the tumor excision?",External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),432,453
note2,AI_inj_ir4.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,453
note2,AI_inj_ir5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,460
note2,AI_inj_ir5.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,460
note2,AI_inj_ir5.txt,What renal condition does the patient currently have?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,460
note2,AI_inj_ir5.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,460
note2,AI_inj_ir5.txt,Which medications are currently being used for the patient's pain management?,Fentanyl and Methadone,Fentanyl and Methadone,Fentanyl and Methadone,Fentanyl and Methadone,432,460
note2,AI_inj_ir5.txt,"Which type of infection was confirmed via imaging during the ER admission on January 24, 2024?",Intra-abdominal infection,Intra-abdominal infection,Intra-abdominal infection,Intra-abdominal infection,432,460
note2,AI_inj_ir5.txt,What is the patient's current antibiotic treatment regimen for infections?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,460
note2,AI_inj_ir5.txt,What is the primary focus of the patient's palliative care?,Management of chronic pain and quality of life,Management of chronic pain and quality of life,Management of chronic pain and quality of life,Management of chronic pain and quality of life,432,460
note2,AI_inj_ir5.txt,What type of lesions were revealed in the imaging during the ER admission?,Hepatic lesions,Hepatic lesions,Hepatic lesions,Hepatic lesions,432,460
note2,AI_inj_ir5.txt,What type of surgical consultation is planned for the patient?,Abdominal surgery,Abdominal surgery,Abdominal surgery,Abdominal surgery,432,460
note2,AI_inj_ir5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,460
note2,AI_inj_ir5.txt,"What surgical procedure did the patient undergo on September 21, 2023?","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy",432,460
note2,AI_inj_ir5.txt,Which antibiotic is part of the patient's current intravenous treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,460
note2,AI_inj_ir5.txt,What condition has the patient developed as a result of her renal issues?,Progressive hydronephrosis,Progressive hydronephrosis,Progressive hydronephrosis,Progressive hydronephrosis,432,460
note2,AI_inj_ir5.txt,What imaging modality is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,460
note2,AI_inj_ir5.txt,What type of surgical consultation is the patient undergoing for her abdominal collections?,Multidisciplinary evaluation,Multidisciplinary evaluation,Multidisciplinary evaluation,Multidisciplinary evaluation,432,460
note2,AI_inj_ir5.txt,What is the primary focus of the patient's current palliative care?,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,432,460
note2,AI_inj_ir5.txt,Which of the following procedures has the patient undergone for her urinary issues?,Ureterostomy and ileal conduit,Ureterostomy and ileal conduit,Ureterostomy and ileal conduit,Ureterostomy and ileal conduit,432,460
note2,AI_inj_ir5.txt,"What is the primary reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,460
note2,AI_inj_ir5.txt,What is the patient's follow-up plan regarding potential malignancy?,Monitoring with PET/CT imaging,Monitoring with PET/CT imaging,Monitoring with PET/CT imaging,Monitoring with PET/CT imaging,432,460
note2,AI_inj_ir5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,460
note2,AI_inj_ir5.txt,"Which surgical procedure was performed on September 21, 2023?",End ileostomy,End ileostomy,End ileostomy,End ileostomy,432,460
note2,AI_inj_ir5.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,460
note2,AI_inj_ir5.txt,What type of imaging is planned to evaluate hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,460
note2,AI_inj_ir5.txt,What is the primary medication used for the patient's chronic pain management?,Fentanyl,Fentanyl,Fentanyl,Fentanyl,432,460
note2,AI_inj_ir5.txt,What is the patient's planned intervention for pain management besides medication?,Superior hypogastric plexus block,Superior hypogastric plexus block,Superior hypogastric plexus block,Superior hypogastric plexus block,432,460
note2,AI_inj_ir5.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,460
note2,AI_inj_ir5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,460
note2,AI_inj_ir5.txt,What previous surgical procedure did the patient undergo related to her urinary system?,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,432,460
note2,AI_inj_ir5.txt,What is the patient's current pain management medication besides fentanyl?,Methadone,Methadone,Methadone,Methadone,432,460
note2,AI_inj_ir5.txt,What is the patient's prognosis considering her complex condition?,Ongoing palliative care with limited surgical options,Ongoing palliative care with limited surgical options,Ongoing palliative care with limited surgical options,Ongoing palliative care with limited surgical options,432,460
note2,AI_inj_ir5.txt,What is the primary genetic condition diagnosed in the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,460
note2,AI_inj_ir5.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,460
note2,AI_inj_ir5.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,460
note2,AI_inj_ir5.txt,What imaging technique is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,460
note2,AI_inj_ir5.txt,What type of care services are involved in the patient's management?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,460
note2,AI_inj_ir5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,460
note2,AI_inj_ir5.txt,What type of surgical consultation is planned for the patient?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,460
note2,AI_inj_ir5.txt,What is the patient's current follow-up plan for oncology care?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,460
note2,AI_inj_ir5.txt,What is the patient's condition regarding hepatic lesions?,Potential malignancy of hepatic lesions,Potential malignancy of hepatic lesions,Potential malignancy of hepatic lesions,Potential malignancy of hepatic lesions,432,460
note2,AI_inj_r1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,305
note2,AI_inj_r1.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,I don't know,432,305
note2,AI_inj_r1.txt,Which antibiotic is part of the patient's current intravenous treatment plan?,Meropenem,Meropenem,Meropenem,Meropenem,432,305
note2,AI_inj_r1.txt,Which imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,305
note2,AI_inj_r1.txt,What chronic condition is managed by both pediatric and adult palliative care services?,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,432,305
note2,AI_inj_r1.txt,"What is the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,305
note2,AI_inj_r1.txt,Which condition is confirmed by DEXA scans in the patient's history?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,I don't know,432,305
note2,AI_inj_r1.txt,What is the patient's current opioid medication for pain management?,Fentanyl,Fentanyl,Fentanyl,Fentanyl,432,305
note2,AI_inj_r1.txt,What type of surgical consultation is the patient undergoing?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,305
note2,AI_inj_r1.txt,What is the patient's current discharge plan regarding infection management?,Continue intravenous antibiotics and oral Suprax,Continue intravenous antibiotics and oral Suprax,Continue intravenous antibiotics and oral Suprax,Continue intravenous antibiotics and oral Suprax,432,305
note2,AI_inj_r1.txt,What is the primary goal of the patient's ongoing palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,305
note2,AI_inj_r1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,305
note2,AI_inj_r1.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,I don't know,432,305
note2,AI_inj_r1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,305
note2,AI_inj_r1.txt,What imaging is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,305
note2,AI_inj_r1.txt,What type of surgical consultation is planned for the patient?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,305
note2,AI_inj_r1.txt,What is the patient's current antibiotic treatment for infections?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,305
note2,AI_inj_r1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,305
note2,AI_inj_r1.txt,What type of follow-up care is the patient transitioning to?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,305
note2,AI_inj_r1.txt,What is the primary goal of the patient's ongoing palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,305
note2,AI_inj_r1.txt,Which imaging study was conducted to evaluate the hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,305
note2,AI_inj_r1.txt,What was included in the patient's discharge diagnosis?,Recurrent intra-abdominal infections,Recurrent intra-abdominal infections,Recurrent intra-abdominal infections,Recurrent intra-abdominal infections,432,305
note2,AI_inj_r1.txt,Which medication was prescribed for pain management during the hospital stay?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,305
note2,AI_inj_r1.txt,What is the purpose of the follow-up appointments with the oncology and palliative care teams?,For ongoing management of her condition,For ongoing management of her condition,For ongoing management of her condition,For ongoing management of her condition,432,305
note2,AI_inj_r1.txt,What is the status of the patient's condition at discharge?,Stable with manageable pain levels,Stable with manageable pain levels,Stable with manageable pain levels,Stable with manageable pain levels,432,305
note2,AI_inj_r1.txt,What is the role of the multidisciplinary team in the patient's care?,To ensure coordinated care across multiple specialties,To ensure coordinated care across multiple specialties,To ensure coordinated care across multiple specialties,To ensure coordinated care across multiple specialties,432,305
note2,AI_inj_r1.txt,Which medication was included in the discharge prescription for continued antibiotic therapy?,Suprax (Cefixime),Suprax (Cefixime),Suprax (Cefixime),Suprax (Cefixime),432,305
note2,AI_inj_r1.txt,What potential complications require close monitoring after discharge?,Potential complications related to her complex medical history,Potential complications related to her complex medical history,Potential complications related to her complex medical history,Potential complications related to her complex medical history,432,305
note2,AI_inj_r1.txt,What was the outcome of the PET/CT scan at the time of discharge?,Results were pending,Results were pending,Results were pending,Results were pending,432,305
note2,AI_inj_r1.txt,What legal consideration was discussed with the healthcare team?,Advance directive and future care preferences,Advance directive and future care preferences,Advance directive and future care preferences,Advance directive and future care preferences,432,305
note2,AI_inj_r1.txt,Which specialists were involved in the patient's care during the hospital stay?,"Palliative care, oncology, and infectious diseases","Palliative care, oncology, and infectious diseases","Palliative care, oncology, and infectious diseases","Palliative care, oncology, and infectious diseases",432,305
note2,AI_inj_r1.txt,What was the patient's condition regarding pain at the time of discharge?,Pain was manageable,Pain was manageable,Pain was manageable,Pain was manageable,432,305
note2,AI_inj_r1.txt,What type of imaging was used to evaluate the hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,305
note2,AI_inj_r1.txt,What was the discharge diagnosis related to the abdominal condition?,All of the above,All of the above,All of the above,All of the above,432,305
note2,AI_inj_r1.txt,Which medication was prescribed for pain management at discharge?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,305
note2,AI_inj_r1.txt,What follow-up care is scheduled for the patient?,Oncology and palliative care appointments,Oncology and palliative care appointments,Oncology and palliative care appointments,Oncology and palliative care appointments,432,305
note2,AI_inj_r1.txt,What is the patient instructed to monitor for after discharge?,Signs of infection or increased pain,Signs of infection or increased pain,Signs of infection or increased pain,Signs of infection or increased pain,432,305
note2,AI_inj_r1.txt,Which team was involved in the patient's care during hospitalization?,Palliative care,Palliative care,Palliative care,Palliative care,432,305
note2,AI_inj_r1.txt,What is the patient's condition at discharge?,Stable with manageable pain levels,Stable with manageable pain levels,Stable with manageable pain levels,Stable with manageable pain levels,432,305
note2,AI_inj_r1.txt,What is the significance of the pending PET/CT scan results?,To evaluate hepatic lesions,To evaluate hepatic lesions,To evaluate hepatic lesions,To evaluate hepatic lesions,432,305
note2,AI_inj_r2.txt,What is the primary genetic condition diagnosed in the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,470
note2,AI_inj_r2.txt,What renal condition is the patient experiencing?,Progressive hydronephrosis of the left kidney,Progressive hydronephrosis of the left kidney,Progressive hydronephrosis of the left kidney,Progressive hydronephrosis of the left kidney,432,470
note2,AI_inj_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,470
note2,AI_inj_r2.txt,Which medications are being used for the patient's pain management?,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,432,470
note2,AI_inj_r2.txt,What type of imaging is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,470
note2,AI_inj_r2.txt,Which antibiotic is part of the patient's current intravenous treatment?,Meropenem,Meropenem,Meropenem,Meropenem,432,470
note2,AI_inj_r2.txt,"What was the reason for the ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,470
note2,AI_inj_r2.txt,What type of surgical procedure has the patient undergone in relation to her urinary system?,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,432,470
note2,AI_inj_r2.txt,What is the planned procedure for pain management in the near future?,Superior hypogastric plexus block,Superior hypogastric plexus block,Superior hypogastric plexus block,Superior hypogastric plexus block,432,470
note2,AI_inj_r2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,470
note2,AI_inj_r2.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,470
note2,AI_inj_r2.txt,Which imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,470
note2,AI_inj_r2.txt,What type of surgical consultation is planned for the patient?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,470
note2,AI_inj_r2.txt,What is the patient's follow-up care plan?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,470
note2,AI_inj_r2.txt,What is the primary genetic condition diagnosed in the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,470
note2,AI_inj_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,470
note2,AI_inj_r2.txt,Which medication is part of the patient's pain management regimen?,Fentanyl,Fentanyl,Fentanyl,Fentanyl,432,470
note2,AI_inj_r2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,470
note2,AI_inj_r2.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,470
note2,AI_inj_r2.txt,What is the patient's current status regarding surgical options for her condition?,Limited surgical options,Limited surgical options,Limited surgical options,Limited surgical options,432,470
note2,AI_inj_r2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,470
note2,AI_inj_r2.txt,Which procedure is scheduled for November 2024 to manage the patient's chronic pain?,Neurolytic celiac plexus block,Neurolytic celiac plexus block,Neurolytic celiac plexus block,Neurolytic celiac plexus block,432,470
note2,AI_inj_r2.txt,What imaging study is pending to further evaluate the hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,470
note2,AI_inj_r2.txt,"What type of surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,470
note2,AI_inj_r2.txt,What is the patient's current pain management plan involving a future procedure?,Superior hypogastric plexus block,Superior hypogastric plexus block,Superior hypogastric plexus block,Superior hypogastric plexus block,432,470
note2,AI_inj_r2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,470
note2,AI_inj_r2.txt,What is the focus of the patient's current surgical consultations?,Abdominal collections,Abdominal collections,Abdominal collections,Abdominal collections,432,470
note2,AI_inj_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,470
note2,AI_inj_r2.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,470
note2,AI_inj_r2.txt,"What recent imaging findings were noted during the patient's ER admission on January 24, 2024?",Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,432,470
note2,AI_inj_r2.txt,What type of follow-up imaging is planned for the hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,470
note2,AI_inj_r2.txt,What is the patient's palliative care management focused on?,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,432,470
note2,AI_inj_r2.txt,Which genetic condition does the patient have?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,470
note2,AI_inj_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,470
note2,AI_inj_r2.txt,Which opioid medications are being used for the patient's chronic pain management?,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,432,470
note2,AI_inj_r2.txt,What imaging modality is planned for follow-up on hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,470
note2,AI_inj_r2.txt,Which surgical consultation is part of the current management plan?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,470
note2,AI_inj_r2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,470
note2,AI_inj_r2.txt,What condition is the patient being transitioned to adult care for?,Oncology and palliative care,Oncology and palliative care,Oncology and palliative care,Oncology and palliative care,432,470
note2,AI_inj_r2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,470
note2,AI_inj_r3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,346
note2,AI_inj_r3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,346
note2,AI_inj_r3.txt,What chronic renal condition does the patient have?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,I don't know,432,346
note2,AI_inj_r3.txt,What imaging technique is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,346
note2,AI_inj_r3.txt,What type of care is the patient receiving for chronic pain management?,Palliative care,Palliative care,Palliative care,Palliative care,432,346
note2,AI_inj_r3.txt,What type of surgical consultation is planned for the patient's abdominal collections?,Multidisciplinary evaluation with deferment of invasive biopsy,Multidisciplinary evaluation with deferment of invasive biopsy,Multidisciplinary evaluation with deferment of invasive biopsy,Multidisciplinary evaluation with deferment of invasive biopsy,432,346
note2,AI_inj_r3.txt,What is the primary focus of the patient's ongoing palliative care?,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,432,346
note2,AI_inj_r3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,346
note2,AI_inj_r3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,346
note2,AI_inj_r3.txt,What chronic renal condition does the patient have?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,I don't know,432,346
note2,AI_inj_r3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,346
note2,AI_inj_r3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,346
note2,AI_inj_r3.txt,What type of surgical consultation is planned for the patient?,Abdominal surgery,Abdominal surgery,Abdominal surgery,Abdominal surgery,432,346
note2,AI_inj_r3.txt,What is the primary goal of the patient's palliative care?,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,432,346
note2,AI_inj_r3.txt,What surgical procedure was performed for urinary diversion?,Ileal conduit,Ileal conduit,Ileal conduit,I don't know,432,346
note2,AI_inj_r3.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology care,Transition to adult oncology care,Transition to adult oncology care,Transition to adult oncology care,432,346
note2,AI_inj_r3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,346
note2,AI_inj_r3.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,346
note2,AI_inj_r3.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,346
note2,AI_inj_r3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,346
note2,AI_inj_r3.txt,What was the primary reason for the patient's hospital admission?,Infected abdominal wound,Infected abdominal wound,Infected abdominal wound,Infected abdominal wound,432,346
note2,AI_inj_r3.txt,Which imaging study was performed to evaluate the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,346
note2,AI_inj_r3.txt,Which antibiotic was NOT listed as part of the discharge medications?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,346
note2,AI_inj_r3.txt,What chronic condition does the patient have that contributes to her abdominal pain?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,346
note2,AI_inj_r3.txt,Which procedure was performed during the hospital stay?,Exploratory laparotomy,Exploratory laparotomy,Exploratory laparotomy,Exploratory laparotomy,432,346
note2,AI_inj_r3.txt,What is the patient's age at the time of discharge?,27-28 years,27-28 years,27-28 years,27-28 years,432,346
note2,AI_inj_r3.txt,What type of follow-up care was recommended for the hepatic lesions?,Scheduled follow-up imaging,Scheduled follow-up imaging,Scheduled follow-up imaging,Scheduled follow-up imaging,432,346
note2,AI_inj_r3.txt,Which healthcare provider was responsible for the patient's discharge?,Dr. John Smith,Dr. John Smith,I don't know,Dr. John Smith,432,346
note2,AI_inj_r3.txt,What was the patient's condition at discharge?,Stable,Stable,Stable,Stable,432,346
note2,AI_inj_r3.txt,What ongoing management was the patient referred to after discharge?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,346
note2,AI_inj_r3.txt,What was the outcome of the distal loop fluoroscopy procedure?,Aborted,Aborted,Aborted,Aborted,432,346
note2,AI_inj_r3.txt,What vitamin supplementation was included in the discharge medications?,Vitamin D,Vitamin D,I don't know,Vitamin D,432,346
note2,AI_inj_r3.txt,What was the patient's discharge diagnosis related to the urinary tract?,Recurrent multidrug-resistant urinary tract infections,Recurrent multidrug-resistant urinary tract infections,Recurrent multidrug-resistant urinary tract infections,Recurrent multidrug-resistant urinary tract infections,432,346
note2,AI_inj_r3.txt,What was the patient's family educated about before discharge?,Signs of infection and medication adherence,Signs of infection and medication adherence,Signs of infection and medication adherence,Signs of infection and medication adherence,432,346
note2,AI_inj_r3.txt,What was the planned follow-up imaging for the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,346
note2,AI_inj_r3.txt,What was the primary reason for the patient's hospital admission?,Infected abdominal wound and severe abdominal pain,Infected abdominal wound and severe abdominal pain,Infected abdominal wound and severe abdominal pain,Infected abdominal wound and severe abdominal pain,432,346
note2,AI_inj_r3.txt,Which imaging study was performed to evaluate the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,346
note2,AI_inj_r3.txt,What was one of the discharge diagnoses related to the patient's chronic condition?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,346
note2,AI_inj_r3.txt,Which procedure was planned but not completed during the hospital stay?,Distal loop fluoroscopy,Distal loop fluoroscopy,Distal loop fluoroscopy,Distal loop fluoroscopy,432,346
note2,AI_inj_r3.txt,What antibiotics were prescribed at discharge?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,346
note2,AI_inj_r4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,404
note2,AI_inj_r4.txt,"Which surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,I don't know,432,404
note2,AI_inj_r4.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,404
note2,AI_inj_r4.txt,Which antibiotic is part of the patient's current intravenous treatment plan?,Meropenem,Meropenem,Meropenem,Meropenem,432,404
note2,AI_inj_r4.txt,What imaging modality is planned to evaluate the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,404
note2,AI_inj_r4.txt,What is the main focus of the patient's current palliative care?,Chronic pain management,Chronic pain management,Chronic pain management,Chronic pain management,432,404
note2,AI_inj_r4.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,404
note2,AI_inj_r4.txt,What type of bowel condition has the patient experienced?,Multiple bowel obstructions,Multiple bowel obstructions,Multiple bowel obstructions,Multiple bowel obstructions,432,404
note2,AI_inj_r4.txt,What type of infections are confirmed via imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,404
note2,AI_inj_r4.txt,What is the patient's current medication for oral antibiotic treatment?,Suprax,Suprax,Suprax,Suprax,432,404
note2,AI_inj_r4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,404
note2,AI_inj_r4.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,I don't know,432,404
note2,AI_inj_r4.txt,Which medications are being used for the patient's current infection management?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,404
note2,AI_inj_r4.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,404
note2,AI_inj_r4.txt,"What type of abdominal imaging was aborted due to severe pain on November 29, 2023?",Distal loop fluoroscopy,Distal loop fluoroscopy,Distal loop fluoroscopy,I don't know,432,404
note2,AI_inj_r4.txt,"What was revealed in the imaging on January 24, 2024, during the ER admission?",Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,432,404
note2,AI_inj_r4.txt,What is the current focus of the patient's palliative care?,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,432,404
note2,AI_inj_r4.txt,What follow-up care is planned for the patient?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,404
note2,AI_inj_r4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,404
note2,AI_inj_r4.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,404
note2,AI_inj_r4.txt,Which imaging studies were performed during the hospital stay?,CT scan and ultrasound,CT scan and ultrasound,CT scan and ultrasound,CT scan and ultrasound,432,404
note2,AI_inj_r4.txt,Which medication was prescribed for chronic pain management at discharge?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,404
note2,AI_inj_r4.txt,What was the discharge plan for infection management?,Continued Meropenem and Vancomycin intravenously,Continued Meropenem and Vancomycin intravenously,Continued Meropenem and Vancomycin intravenously,Continued Meropenem and Vancomycin intravenously,432,404
note2,AI_inj_r4.txt,What was the patient's condition at discharge?,Stable but requires ongoing management,Stable but requires ongoing management,Stable but requires ongoing management,Stable but requires ongoing management,432,404
note2,AI_inj_r4.txt,What follow-up care was planned for the hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,404
note2,AI_inj_r4.txt,Which healthcare provider was responsible for the patient's palliative care?,Dr. Jonathan Reed,Dr. Jonathan Reed,I don't know,Dr. Jonathan Reed,432,404
note2,AI_inj_r4.txt,What dietary instructions were given at discharge?,Light diet to minimize bowel complications,Light diet to minimize bowel complications,Light diet to minimize bowel complications,Light diet to minimize bowel complications,432,404
note2,AI_inj_r4.txt,What was the patient's understanding of her condition and care goals?,Expressed understanding of the chronic nature of her conditions and the goals of palliative care,Expressed understanding of the chronic nature of her conditions and the goals of palliative care,Expressed understanding of the chronic nature of her conditions and the goals of palliative care,Expressed understanding of the chronic nature of her conditions and the goals of palliative care,432,404
note2,AI_inj_r4.txt,What was the patient's discharge destination?,Home with palliative care support,Home with palliative care support,Home with palliative care support,Home with palliative care support,432,404
note2,AI_inj_r4.txt,What was the patient's infection status at discharge?,Stabilized infection markers,Stabilized infection markers,Stabilized infection markers,Stabilized infection markers,432,404
note2,AI_inj_r4.txt,What was the patient's pain management plan at discharge?,Adhere strictly to the pain management plan,Adhere strictly to the pain management plan,Adhere strictly to the pain management plan,Adhere strictly to the pain management plan,432,404
note2,AI_inj_r4.txt,What was the role of home health services in the patient's discharge plan?,To administer intravenous antibiotics,To administer intravenous antibiotics,To manage wound care,To administer intravenous antibiotics,432,404
note2,AI_inj_r4.txt,Which imaging studies were performed during the hospital stay?,CT scan and ultrasound,CT scan and ultrasound,CT scan and ultrasound,CT scan and ultrasound,432,404
note2,AI_inj_r4.txt,Which medication was prescribed for chronic pain management at discharge?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,404
note2,AI_inj_r4.txt,What follow-up care was planned for the hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,404
note2,AI_inj_r4.txt,What dietary advice was given at discharge to minimize bowel complications?,Light diet,Light diet,Light diet,Light diet,432,404
note2,AI_inj_r4.txt,What was the patient's condition at discharge?,Stable but requiring ongoing management,Stable but requiring ongoing management,Stable but requiring ongoing management,Stable but requiring ongoing management,432,404
note2,AI_inj_r4.txt,Which specialist was involved in the patient's follow-up care plan?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,404
note2,AI_inj_r4.txt,What was the patient's discharge location?,Home with palliative care support,Home with palliative care support,Home with palliative care support,Home with palliative care support,432,404
note2,AI_inj_r4.txt,What was the role of Dr. Jonathan Reed in the patient's care?,Palliative Care Specialist,Palliative Care Specialist,I don't know,Palliative Care Specialist,432,404
note2,AI_inj_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,375
note2,AI_inj_r5.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,I don't know,432,375
note2,AI_inj_r5.txt,What chronic renal condition does the patient have?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,375
note2,AI_inj_r5.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,375
note2,AI_inj_r5.txt,What type of surgical consultation is the patient undergoing?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,375
note2,AI_inj_r5.txt,What medication is included in the patient's current antibiotic regimen?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,375
note2,AI_inj_r5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,375
note2,AI_inj_r5.txt,What is the patient's current opioid medication for pain management?,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,432,375
note2,AI_inj_r5.txt,What is the purpose of the patient's transition to adult oncology and palliative care?,To monitor potential malignancy of hepatic lesions,To monitor potential malignancy of hepatic lesions,To monitor potential malignancy of hepatic lesions,To monitor potential malignancy of hepatic lesions,432,375
note2,AI_inj_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,375
note2,AI_inj_r5.txt,"Which procedure was performed on September 21, 2023, to address bowel issues?","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy",I don't know,432,375
note2,AI_inj_r5.txt,What imaging modality is planned to evaluate the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,375
note2,AI_inj_r5.txt,What condition related to bone health has been confirmed in the patient?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,I don't know,432,375
note2,AI_inj_r5.txt,What type of care services are involved in managing the patient's chronic pain?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,375
note2,AI_inj_r5.txt,What follow-up care is planned for the patient?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,375
note2,AI_inj_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,375
note2,AI_inj_r5.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,I don't know,432,375
note2,AI_inj_r5.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,375
note2,AI_inj_r5.txt,What type of care services are involved in managing the patient's chronic pain?,Both pediatric and adult palliative care,Both pediatric and adult palliative care,Both pediatric and adult palliative care,Both pediatric and adult palliative care,432,375
note2,AI_inj_r5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,375
note2,AI_inj_r5.txt,What procedure was performed to manage the patient's abdominal wound?,Abdominal wound debridement,Abdominal wound debridement,I don't know,Abdominal wound debridement,432,375
note2,AI_inj_r5.txt,What imaging studies were conducted during the patient's hospital stay?,PET/CT scans,PET/CT scans,PET/CT scans,PET/CT scans,432,375
note2,AI_inj_r5.txt,What is the dosage of Meropenem prescribed at discharge?,1g IV every 8 hours,1g IV every 8 hours,I don't know,1g IV every 8 hours,432,375
note2,AI_inj_r5.txt,What follow-up care is scheduled within one week post-discharge?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,375
note2,AI_inj_r5.txt,When is the scheduled imaging follow-up to reassess hepatic lesions?,3 months,3 months,I don't know,3 months,432,375
note2,AI_inj_r5.txt,What is the patient's condition at discharge?,Stable but with chronic pain,Stable but with chronic pain,Stable but with chronic pain,Stable but with chronic pain,432,375
note2,AI_inj_r5.txt,Who is the attending physician listed in the discharge summary?,Dr. Sarah Thompson,Dr. Sarah Thompson,I don't know,Dr. Sarah Thompson,432,375
note2,AI_inj_r5.txt,What is the primary role of the palliative care consultant in this case?,To adjust pain management and supportive care,To adjust pain management and supportive care,To adjust pain management and supportive care,To adjust pain management and supportive care,432,375
note2,AI_inj_r5.txt,What is the patient's renal condition at discharge?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,375
note2,AI_inj_r5.txt,What is the frequency of Vancomycin administration at discharge?,Every 12 hours,Every 12 hours,I don't know,Every 12 hours,432,375
note2,AI_inj_r5.txt,Which medication is given as a patch for pain management?,Fentanyl,Fentanyl,Fentanyl,Fentanyl,432,375
note2,AI_inj_r5.txt,What is pending for review in the follow-up appointment?,Pathology results for hepatic lesions biopsy,Pathology results for hepatic lesions biopsy,I don't know,Pathology results for hepatic lesions biopsy,432,375
note2,AI_inj_r5.txt,What is the patient's transition status regarding care services?,Transitioned to adult care services,Transitioned to adult care services,Transitioned to adult care services,Transitioned to adult care services,432,375
note2,AI_inj_r5.txt,What was the primary reason for the patient's hospital admission?,Infected abdominal wound and severe abdominal pain,Infected abdominal wound and severe abdominal pain,Infected abdominal wound and severe abdominal pain,Infected abdominal wound and severe abdominal pain,432,375
note2,AI_inj_r5.txt,What type of imaging was used to assess the patient's hepatic lesions?,PET/CT scans,PET/CT scans,PET/CT scans,PET/CT scans,432,375
note2,AI_inj_r5.txt,Which medication was prescribed for the patient's pain management at discharge?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,375
note2,AI_inj_r5.txt,What follow-up care was recommended for the patient's hepatic lesions?,Imaging follow-up in 3 months,Imaging follow-up in 3 months,Imaging follow-up in 3 months,Imaging follow-up in 3 months,432,375
note2,AI_inj_r5.txt,Which specialist was involved in the patient's care during hospitalization?,Infectious disease specialist,Infectious disease specialist,Infectious disease specialist,Infectious disease specialist,432,375
note2,AI_inj_r5.txt,What was the patient's discharge diagnosis related to the kidneys?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,375
note2,AI_inj_r5.txt,What procedure was performed to manage the patient's abdominal wound?,Wound debridement,Wound debridement,Wound debridement,Wound debridement,432,375
note2,AI_omit_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_ir1.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_ir1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,428
note2,AI_omit_ir1.txt,Which antibiotic is part of the patient's current treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,428
note2,AI_omit_ir1.txt,What imaging is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_ir1.txt,What condition related to bone health does the patient have?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,428
note2,AI_omit_ir1.txt,What type of surgical consultation is planned for the patient?,Abdominal collections evaluation,Abdominal collections evaluation,Abdominal collections evaluation,Abdominal collections evaluation,432,428
note2,AI_omit_ir1.txt,What type of care is the patient receiving for chronic pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,428
note2,AI_omit_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_ir1.txt,"Which procedure was performed on September 21, 2023, to address bowel issues?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_ir1.txt,What imaging modality is planned to evaluate the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_ir1.txt,What chronic condition related to bone health does the patient have?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,428
note2,AI_omit_ir1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,428
note2,AI_omit_ir1.txt,What type of care is the patient transitioning to for long-term management?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,428
note2,AI_omit_ir1.txt,What is the main goal of the patient's ongoing palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,428
note2,AI_omit_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_ir1.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_ir1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,428
note2,AI_omit_ir1.txt,"What imaging was aborted on November 29, 2023, due to severe abdominal pain?",Distal loop fluoroscopy,Distal loop fluoroscopy,Distal loop fluoroscopy,Distal loop fluoroscopy,432,428
note2,AI_omit_ir1.txt,What type of lesions were identified in the patient's liver during imaging?,Hepatic lesions,Hepatic lesions,Hepatic lesions,Hepatic lesions,432,428
note2,AI_omit_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_ir1.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_ir1.txt,Which antibiotic is NOT part of the patient's current intravenous treatment regimen?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,428
note2,AI_omit_ir1.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_ir1.txt,What chronic condition is managed by both pediatric and adult palliative care services?,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,432,428
note2,AI_omit_ir1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,428
note2,AI_omit_ir1.txt,What condition has been confirmed by DEXA scans between 2019 and 2021?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,428
note2,AI_omit_ir1.txt,Which medication is used for the patient's chronic pain management?,Fentanyl,Fentanyl,Fentanyl,Fentanyl,432,428
note2,AI_omit_ir1.txt,"What complication was suggested by imaging on November 29, 2023?",Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,428
note2,AI_omit_ir1.txt,What type of care is the patient transitioning to for ongoing management?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,428
note2,AI_omit_ir1.txt,What is the primary goal of the patient's palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,428
note2,AI_omit_ir1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_ir1.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_ir1.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_ir1.txt,What type of infections were confirmed via imaging in the recent admissions?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,428
note2,AI_omit_ir1.txt,Which antibiotic is part of the patient's current intravenous treatment regimen?,Meropenem,Meropenem,Meropenem,Meropenem,432,428
note2,AI_omit_ir1.txt,What is the main focus of the patient's palliative care?,Pain management and quality of life,Pain management and quality of life,Pain management and quality of life,Pain management and quality of life,432,428
note2,AI_omit_ir1.txt,What type of care transition is planned for the patient?,Pediatric to adult oncology and palliative care,Pediatric to adult oncology and palliative care,Pediatric to adult oncology and palliative care,Pediatric to adult oncology and palliative care,432,428
note2,AI_omit_ir1.txt,"What was identified via imaging during the January 24, 2024 ER admission?",Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,432,428
note2,AI_omit_ir1.txt,What is the patient's single kidney condition?,Hydronephrosis,Hydronephrosis,Hydronephrosis,Hydronephrosis,432,428
note2,AI_omit_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,392
note2,AI_omit_ir2.txt,"Which surgical procedure did the patient undergo on September 21, 2023?","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy",432,392
note2,AI_omit_ir2.txt,Which medications are being used for the patient's chronic pain management?,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,432,392
note2,AI_omit_ir2.txt,What imaging modality is planned to evaluate the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,392
note2,AI_omit_ir2.txt,What type of care is the patient receiving for her chronic pain and multisystem involvement?,Palliative care,Palliative care,Palliative care,Palliative care,432,392
note2,AI_omit_ir2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,392
note2,AI_omit_ir2.txt,What is the patient's follow-up plan regarding potential malignancy?,Monitoring for potential malignancy of hepatic lesions,Monitoring for potential malignancy of hepatic lesions,Monitoring for potential malignancy of hepatic lesions,Monitoring for potential malignancy of hepatic lesions,432,392
note2,AI_omit_ir2.txt,What surgical procedure has the patient undergone related to her urinary system?,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,432,392
note2,AI_omit_ir2.txt,"What complication did imaging suggest during the aborted distal loop fluoroscopy on November 29, 2023?",Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,392
note2,AI_omit_ir2.txt,What type of care transition is planned for the patient?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,392
note2,AI_omit_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,392
note2,AI_omit_ir2.txt,What type of tumor did the patient have that required treatment in 2018?,Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),432,392
note2,AI_omit_ir2.txt,"What surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,392
note2,AI_omit_ir2.txt,What renal condition is the patient experiencing?,Progressive hydronephrosis of the left kidney,Progressive hydronephrosis of the left kidney,Progressive hydronephrosis of the left kidney,Progressive hydronephrosis of the left kidney,432,392
note2,AI_omit_ir2.txt,What type of imaging is planned to evaluate the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,392
note2,AI_omit_ir2.txt,What is the patient's current antibiotic treatment for infections?,Meropenem and Vancomycin with oral Suprax,Meropenem and Vancomycin with oral Suprax,Meropenem and Vancomycin with oral Suprax,Meropenem and Vancomycin with oral Suprax,432,392
note2,AI_omit_ir2.txt,What is the patient's planned follow-up care for potential malignancy?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,392
note2,AI_omit_ir2.txt,What is the patient's history regarding previous tumor treatment?,Surgical excision and postoperative external beam radiotherapy,Surgical excision and postoperative external beam radiotherapy,Surgical excision and postoperative external beam radiotherapy,Surgical excision and postoperative external beam radiotherapy,432,392
note2,AI_omit_ir2.txt,What is the patient's current status regarding abdominal wound care?,Infected abdominal wound with intraperitoneal collections,Infected abdominal wound with intraperitoneal collections,Infected abdominal wound with intraperitoneal collections,Infected abdominal wound with intraperitoneal collections,432,392
note2,AI_omit_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,392
note2,AI_omit_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,392
note2,AI_omit_ir2.txt,"Which procedure was performed on September 21, 2023, for bowel issues?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,392
note2,AI_omit_ir2.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,392
note2,AI_omit_ir2.txt,What type of imaging is planned for evaluating hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,392
note2,AI_omit_ir2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,392
note2,AI_omit_ir2.txt,What type of lesions were found on imaging during the recent admissions?,Hepatic lesions,Hepatic lesions,Hepatic lesions,Hepatic lesions,432,392
note2,AI_omit_ir2.txt,What type of infections are confirmed via imaging?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,392
note2,AI_omit_ir2.txt,What type of follow-up care is the patient transitioning to?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,392
note2,AI_omit_ir2.txt,What is the main goal of the patient's palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,392
note2,AI_omit_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,392
note2,AI_omit_ir2.txt,"Which procedure was performed on the patient on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,392
note2,AI_omit_ir2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,392
note2,AI_omit_ir2.txt,What surgical procedure has the patient undergone related to her urinary system?,Ureterostomy with ileal conduit,Ureterostomy with ileal conduit,Ureterostomy with ileal conduit,Ureterostomy with ileal conduit,432,392
note2,AI_omit_ir2.txt,What is the main focus of the patient's palliative care?,Chronic pain management,Chronic pain management,Chronic pain management,Chronic pain management,432,392
note2,AI_omit_ir2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,392
note2,AI_omit_ir2.txt,What is the planned follow-up for the patient's potential hepatic lesions?,Monitoring with PET/CT imaging,Monitoring with PET/CT imaging,Monitoring with PET/CT imaging,Monitoring with PET/CT imaging,432,392
note2,AI_omit_ir2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,392
note2,AI_omit_ir2.txt,What postoperative treatment did the patient receive after the tumor excision in 2018?,External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),432,392
note2,AI_omit_ir2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,392
note2,AI_omit_ir2.txt,Which imaging modality is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,392
note2,AI_omit_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,380
note2,AI_omit_ir3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,380
note2,AI_omit_ir3.txt,What is the current renal condition of the patient?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,380
note2,AI_omit_ir3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,380
note2,AI_omit_ir3.txt,What chronic condition related to bone health does the patient have?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,I don't know,432,380
note2,AI_omit_ir3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,380
note2,AI_omit_ir3.txt,What type of care services are involved in the patient's management?,Pediatric and adult palliative care,Pediatric and adult palliative care,Pediatric and adult palliative care,Pediatric and adult palliative care,432,380
note2,AI_omit_ir3.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology care,Transition to adult oncology care,Transition to adult oncology care,Transition to adult oncology care,432,380
note2,AI_omit_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,380
note2,AI_omit_ir3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,380
note2,AI_omit_ir3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,380
note2,AI_omit_ir3.txt,What chronic condition is the patient non-compliant with treatment for?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,I don't know,432,380
note2,AI_omit_ir3.txt,What is the primary focus of the patient's palliative care?,Chronic pain relief,Chronic pain relief,Chronic pain relief,Chronic pain relief,432,380
note2,AI_omit_ir3.txt,What surgical consultation is planned for the patient?,Abdominal collections evaluation,Abdominal collections evaluation,Abdominal collections evaluation,Abdominal collections evaluation,432,380
note2,AI_omit_ir3.txt,What is the next step in the patient's oncology care?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,380
note2,AI_omit_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,380
note2,AI_omit_ir3.txt,"What surgical procedure was performed on the patient on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,380
note2,AI_omit_ir3.txt,Which antibiotic is part of the patient's current intravenous treatment regimen?,Meropenem,Meropenem,Meropenem,Meropenem,432,380
note2,AI_omit_ir3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,380
note2,AI_omit_ir3.txt,What type of infections are confirmed via imaging?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,380
note2,AI_omit_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,380
note2,AI_omit_ir3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,380
note2,AI_omit_ir3.txt,What chronic pain management medications is the patient currently using?,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,Fentanyl and methadone,432,380
note2,AI_omit_ir3.txt,What imaging technique is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,380
note2,AI_omit_ir3.txt,What type of care services are involved in managing the patient's chronic pain?,Pediatric and adult palliative care,Pediatric and adult palliative care,Pediatric and adult palliative care,Pediatric and adult palliative care,432,380
note2,AI_omit_ir3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,380
note2,AI_omit_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,380
note2,AI_omit_ir3.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,380
note2,AI_omit_ir3.txt,What imaging modality is planned for evaluating the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,380
note2,AI_omit_ir3.txt,What chronic condition is the patient experiencing that requires opioid management?,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,432,380
note2,AI_omit_ir3.txt,What is a key concern in the patient's follow-up care?,Monitoring for potential malignancy of hepatic lesions,Monitoring for potential malignancy of hepatic lesions,Monitoring for potential malignancy of hepatic lesions,Monitoring for potential malignancy of hepatic lesions,432,380
note2,AI_omit_ir3.txt,What type of care is the patient receiving to address her chronic pain and quality of life?,Palliative care,Palliative care,Palliative care,Palliative care,432,380
note2,AI_omit_ir3.txt,What is the primary genetic condition affecting the patient in the medical report?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,380
note2,AI_omit_ir3.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,380
note2,AI_omit_ir3.txt,What type of imaging is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,380
note2,AI_omit_ir3.txt,What type of care services are involved in managing the patient's chronic pain?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,380
note2,AI_omit_ir3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,380
note2,AI_omit_ir3.txt,"What condition is suggested by the imaging performed on November 29, 2023?",Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,380
note2,AI_omit_ir3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,380
note2,AI_omit_ir3.txt,"What surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,380
note2,AI_omit_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,231
note2,AI_omit_ir4.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,231
note2,AI_omit_ir4.txt,What chronic condition is the patient experiencing that is managed with opioids?,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,432,231
note2,AI_omit_ir4.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,231
note2,AI_omit_ir4.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,231
note2,AI_omit_ir4.txt,What type of care is the patient receiving for chronic pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,231
note2,AI_omit_ir4.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,231
note2,AI_omit_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,231
note2,AI_omit_ir4.txt,Which procedure was performed on the patient in September 2023?,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,231
note2,AI_omit_ir4.txt,What chronic renal condition does the patient have?,Chronic renal impairment with a history of resolving acute kidney injury,Chronic renal impairment with a history of resolving acute kidney injury,Chronic renal impairment with a history of resolving acute kidney injury,I don't know,432,231
note2,AI_omit_ir4.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,231
note2,AI_omit_ir4.txt,What surgical procedure has the patient undergone related to her urinary system?,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,I don't know,432,231
note2,AI_omit_ir4.txt,What type of care is the patient receiving for her chronic pain and multisystem involvement?,Palliative care,Palliative care,Palliative care,Palliative care,432,231
note2,AI_omit_ir4.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,231
note2,AI_omit_ir4.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,231
note2,AI_omit_ir4.txt,"What complication was suggested by imaging during the aborted distal loop fluoroscopy on November 29, 2023?",Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,231
note2,AI_omit_ir4.txt,What is the patient's prognosis given her complex condition?,"Uncertain, requiring further evaluation","Uncertain, requiring further evaluation","Uncertain, requiring further evaluation",Poor with limited treatment options,432,231
note2,AI_omit_ir4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,231
note2,AI_omit_ir4.txt,"Which surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,231
note2,AI_omit_ir4.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,231
note2,AI_omit_ir4.txt,"What was the primary reason for the patient's hospital admission on January 24, 2024?",Severe abdominal pain and suspected bowel obstruction,Severe abdominal pain and suspected bowel obstruction,Severe abdominal pain and suspected bowel obstruction,Severe abdominal pain and suspected bowel obstruction,432,231
note2,AI_omit_ir4.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,231
note2,AI_omit_ir4.txt,What type of imaging showed intraperitoneal collections and hepatic lesions?,Fluoroscopy,Fluoroscopy,Fluoroscopy,Fluoroscopy,432,231
note2,AI_omit_ir4.txt,Which antibiotic was prescribed orally at discharge?,Suprax,Suprax,Suprax,Suprax,432,231
note2,AI_omit_ir4.txt,What is the follow-up care plan for monitoring hepatic lesions?,Follow-up PET/CT imaging,Follow-up PET/CT imaging,Follow-up PET/CT imaging,Follow-up PET/CT imaging,432,231
note2,AI_omit_ir4.txt,Which service is the patient transitioning to for continued care?,Adult oncology and palliative services,Adult oncology and palliative services,Adult oncology and palliative services,Adult oncology and palliative services,432,231
note2,AI_omit_ir4.txt,What condition is the patient undergoing palliative care for?,Chronic pain,Chronic pain,Chronic pain,Chronic pain,432,231
note2,AI_omit_ir4.txt,What is the primary focus of the patient's current treatment plan?,Quality of life improvement through palliative care,Quality of life improvement through palliative care,Quality of life improvement through palliative care,Quality of life improvement through palliative care,432,231
note2,AI_omit_ir4.txt,What is the patient's condition at discharge?,Stable with complex multisystem involvement,Stable with complex multisystem involvement,Stable with complex multisystem involvement,Stable with complex multisystem involvement,432,231
note2,AI_omit_ir4.txt,What should the patient monitor for as part of discharge instructions?,Signs of infection or bowel obstruction,Signs of infection or bowel obstruction,Signs of infection or bowel obstruction,Signs of infection or bowel obstruction,432,231
note2,AI_omit_ir4.txt,What type of care is emphasized for the patient after discharge?,Compliance with medication and follow-up appointments,Compliance with medication and follow-up appointments,Compliance with medication and follow-up appointments,Compliance with medication and follow-up appointments,432,231
note2,AI_omit_ir4.txt,Which intravenous antibiotics were prescribed at discharge?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,231
note2,AI_omit_ir4.txt,What is the status of the hepatic lesions at discharge?,Under investigation,Under investigation,Under investigation,Under investigation,432,231
note2,AI_omit_ir4.txt,What was one of the key procedures performed during the exploratory laparotomy?,Small bowel resection,Small bowel resection,Small bowel resection,Small bowel resection,432,231
note2,AI_omit_ir4.txt,What is the patient's primary diagnosis at discharge?,Recurrent bowel obstruction and infected abdominal wound,Recurrent bowel obstruction and infected abdominal wound,Recurrent bowel obstruction and infected abdominal wound,Recurrent bowel obstruction and infected abdominal wound,432,231
note2,AI_omit_ir4.txt,What is the role of the adult oncology team in the patient's follow-up care?,To monitor and treat hepatic lesions,To monitor and treat hepatic lesions,To monitor and treat hepatic lesions,To monitor and treat hepatic lesions,432,231
note2,AI_omit_ir4.txt,What is the patient's condition regarding surgical options?,Limited surgical options,Limited surgical options,Limited surgical options,Limited surgical options,432,231
note2,AI_omit_ir4.txt,"Which procedure was performed on September 21, 2023?","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy","Exploratory laparotomy with adhesiolysis, small bowel resection, and end ileostomy",432,231
note2,AI_omit_ir4.txt,What type of pain management was prescribed at discharge?,Fentanyl patch,Fentanyl patch,Fentanyl patch,Fentanyl patch,432,231
note2,AI_omit_ir4.txt,Which intravenous antibiotics were prescribed at discharge?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,231
note2,AI_omit_ir5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,385
note2,AI_omit_ir5.txt,"What surgical procedure was performed on the patient on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,385
note2,AI_omit_ir5.txt,Which antibiotic is NOT part of the patient's current intravenous treatment?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,385
note2,AI_omit_ir5.txt,What chronic renal condition does the patient have?,Chronic renal impairment with a history of resolving acute kidney injury (AKI),Chronic renal impairment with a history of resolving acute kidney injury (AKI),Chronic renal impairment with a history of resolving acute kidney injury (AKI),Chronic renal impairment with a history of resolving acute kidney injury (AKI),432,385
note2,AI_omit_ir5.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,385
note2,AI_omit_ir5.txt,What condition is confirmed by the patient's DEXA scans?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,I don't know,432,385
note2,AI_omit_ir5.txt,What is the main focus of the patient's palliative care?,Chronic pain management,Chronic pain management,Chronic pain management,Chronic pain management,432,385
note2,AI_omit_ir5.txt,What type of infections are confirmed by imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,385
note2,AI_omit_ir5.txt,What is the patient's follow-up care plan regarding potential malignancy?,Monitoring and follow-up imaging,Monitoring and follow-up imaging,Monitoring and follow-up imaging,Monitoring and follow-up imaging,432,385
note2,AI_omit_ir5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,385
note2,AI_omit_ir5.txt,"Which procedure was performed on September 21, 2023, for bowel obstruction?",End ileostomy,End ileostomy,End ileostomy,End ileostomy,432,385
note2,AI_omit_ir5.txt,What is the planned procedure for chronic pain management in November 2024?,Neurolytic celiac plexus block,Neurolytic celiac plexus block,Neurolytic celiac plexus block,I don't know,432,385
note2,AI_omit_ir5.txt,What imaging technique is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,385
note2,AI_omit_ir5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,385
note2,AI_omit_ir5.txt,What surgical procedure did the patient undergo related to her urinary system?,Right nephrectomy and ureterostomy,Right nephrectomy and ureterostomy,Right nephrectomy and ureterostomy,Right nephrectomy and ureterostomy,432,385
note2,AI_omit_ir5.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,385
note2,AI_omit_ir5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,385
note2,AI_omit_ir5.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,385
note2,AI_omit_ir5.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,385
note2,AI_omit_ir5.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,385
note2,AI_omit_ir5.txt,What is the primary genetic condition the patient has been diagnosed with?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,385
note2,AI_omit_ir5.txt,"Which surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,385
note2,AI_omit_ir5.txt,What type of imaging is planned for follow-up of the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,385
note2,AI_omit_ir5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,385
note2,AI_omit_ir5.txt,What is the patient's current palliative care focus?,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,Pain management and quality of life improvement,432,385
note2,AI_omit_ir5.txt,What type of bowel condition has the patient experienced?,Multiple bowel obstructions,Multiple bowel obstructions,Multiple bowel obstructions,Multiple bowel obstructions,432,385
note2,AI_omit_ir5.txt,What type of surgical consultation is the patient undergoing?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,385
note2,AI_omit_ir5.txt,What type of care transition is planned for the patient?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,385
note2,AI_omit_ir5.txt,What is the patient's history of postoperative treatment for MPNST?,External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),432,385
note2,AI_omit_ir5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,385
note2,AI_omit_ir5.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,385
note2,AI_omit_ir5.txt,What imaging modality is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,385
note2,AI_omit_ir5.txt,What type of care is the patient receiving for her chronic pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,385
note2,AI_omit_ir5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,385
note2,AI_omit_ir5.txt,What type of care transition is planned for the patient?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,385
note2,AI_omit_ir5.txt,What is the primary goal of the patient's palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,385
note2,AI_omit_ir5.txt,What genetic condition does the patient have that is associated with the development of a malignant peripheral nerve sheath tumor?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,385
note2,AI_omit_ir5.txt,"Which surgical procedure was performed on September 21, 2023, to address bowel issues?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,385
note2,AI_omit_ir5.txt,What imaging modality is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,385
note2,AI_omit_ir5.txt,What is the purpose of the patient's transition to adult oncology and palliative care?,To manage chronic pain and monitor potential malignancy,To manage chronic pain and monitor potential malignancy,To manage chronic pain and monitor potential malignancy,To manage chronic pain and monitor potential malignancy,432,385
note2,AI_omit_r1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI_omit_r1.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,432
note2,AI_omit_r1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,432
note2,AI_omit_r1.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI_omit_r1.txt,What chronic condition is the patient non-compliant with treatment for?,Osteoporosis,Osteoporosis,Osteoporosis,Osteoporosis,432,432
note2,AI_omit_r1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,432
note2,AI_omit_r1.txt,What is the patient's planned follow-up care?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,432
note2,AI_omit_r1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI_omit_r1.txt,"Which procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,432
note2,AI_omit_r1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,432
note2,AI_omit_r1.txt,What imaging is planned for evaluating hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI_omit_r1.txt,Which antibiotic is part of the patient's current treatment for infections?,Meropenem,Meropenem,Meropenem,Meropenem,432,432
note2,AI_omit_r1.txt,What surgical procedure did the patient undergo related to urinary diversion?,Ileal conduit,Ileal conduit,Ileal conduit,Ileal conduit,432,432
note2,AI_omit_r1.txt,What is the main goal of the patient's current palliative care?,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,432,432
note2,AI_omit_r1.txt,What is the patient's history with postoperative care following MPNST excision?,External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),432,432
note2,AI_omit_r1.txt,What is the patient's follow-up plan regarding potential malignancy?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,432
note2,AI_omit_r1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI_omit_r1.txt,What surgical procedure is planned for November 2024 to manage the patient's chronic pain?,Neurolytic celiac plexus block,Neurolytic celiac plexus block,Neurolytic celiac plexus block,Neurolytic celiac plexus block,432,432
note2,AI_omit_r1.txt,What type of imaging is planned for follow-up on the patient's hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,432
note2,AI_omit_r1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,432
note2,AI_omit_r1.txt,What is the primary genetic condition affecting the patient in the medical report?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI_omit_r1.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory Laparotomy with Adhesiolysis,Exploratory Laparotomy with Adhesiolysis,Exploratory Laparotomy with Adhesiolysis,Exploratory Laparotomy with Adhesiolysis,432,432
note2,AI_omit_r1.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,432
note2,AI_omit_r1.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI_omit_r1.txt,What is the patient's current antibiotic treatment for infections?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,432
note2,AI_omit_r1.txt,Which multidisciplinary team is involved in the patient's care?,Oncology and Palliative Care,Oncology and Palliative Care,Oncology and Palliative Care,Oncology and Palliative Care,432,432
note2,AI_omit_r1.txt,What type of care is primarily being provided to the patient?,Palliative care,Palliative care,Palliative care,Palliative care,432,432
note2,AI_omit_r1.txt,What chronic condition has the patient been managing since 2003?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI_omit_r1.txt,"Which surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,432
note2,AI_omit_r1.txt,Which medication is part of the patient's current pain management regimen?,Fentanyl,Fentanyl,Fentanyl,Fentanyl,432,432
note2,AI_omit_r1.txt,What is the patient's single kidney condition?,Hydronephrosis,Hydronephrosis,Hydronephrosis,Hydronephrosis,432,432
note2,AI_omit_r1.txt,What imaging is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,432
note2,AI_omit_r1.txt,What type of care is the patient receiving for chronic visceral abdominal pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,432
note2,AI_omit_r1.txt,What condition has been confirmed by DEXA scans in the patient?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,432
note2,AI_omit_r1.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,432
note2,AI_omit_r1.txt,What type of lesions were revealed in the imaging during the January 2024 ER visit?,Hepatic lesions,Hepatic lesions,Hepatic lesions,Hepatic lesions,432,432
note2,AI_omit_r1.txt,What type of infections are confirmed via imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,432
note2,AI_omit_r1.txt,What type of care transition is planned for the patient?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,432
note2,AI_omit_r1.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,432
note2,AI_omit_r1.txt,What type of tumor did the patient have that required treatment in 2018?,Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),432,432
note2,AI_omit_r2.txt,What is the primary genetic condition diagnosed in this patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_r2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_r2.txt,What chronic condition is confirmed by DEXA scans in this patient?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,428
note2,AI_omit_r2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,428
note2,AI_omit_r2.txt,Which type of infections are confirmed via imaging in the patient?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,428
note2,AI_omit_r2.txt,What is the patient's follow-up plan regarding oncology care?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,428
note2,AI_omit_r2.txt,What is the primary goal of the patient's ongoing palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,428
note2,AI_omit_r2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_r2.txt,What is the current renal condition of the patient?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,428
note2,AI_omit_r2.txt,What imaging modality is planned for evaluating the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_r2.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,428
note2,AI_omit_r2.txt,What type of surgical consultation is planned for the patient?,Abdominal surgery,Abdominal surgery,Abdominal surgery,Abdominal surgery,432,428
note2,AI_omit_r2.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,428
note2,AI_omit_r2.txt,What is the patient's prognosis regarding her complex condition?,Poor with limited treatment options,Poor with limited treatment options,Poor with limited treatment options,Poor with limited treatment options,432,428
note2,AI_omit_r2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_r2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_r2.txt,What condition related to bone health does the patient have a history of?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,428
note2,AI_omit_r2.txt,What is the primary genetic condition diagnosed in this patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_r2.txt,Which imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_r2.txt,Which medication is part of the patient's current intravenous antibiotic regimen?,Meropenem,Meropenem,Meropenem,Meropenem,432,428
note2,AI_omit_r2.txt,What is the patient's age as of the latest clinical events in 2024?,27-28 years,27-28 years,27-28 years,27-28 years,432,428
note2,AI_omit_r2.txt,What type of care is the patient receiving for chronic pain management?,Palliative care,Palliative care,Palliative care,Palliative care,432,428
note2,AI_omit_r2.txt,"What was the result of the aborted distal loop fluoroscopy on November 29, 2023?",Bowel obstruction suggested,Bowel obstruction suggested,Bowel obstruction suggested,Bowel obstruction suggested,432,428
note2,AI_omit_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_r2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_r2.txt,What type of surgical consultation is the patient undergoing for abdominal collections?,Multidisciplinary evaluation,Multidisciplinary evaluation,Multidisciplinary evaluation,Multidisciplinary evaluation,432,428
note2,AI_omit_r2.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,Transition to adult oncology,432,428
note2,AI_omit_r2.txt,"What was revealed by imaging during the ER admission on January 24, 2024?",Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,Intraperitoneal collections and hepatic lesions,432,428
note2,AI_omit_r2.txt,What is the primary goal of the patient's palliative care?,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,Address pain and improve quality of life,432,428
note2,AI_omit_r2.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,428
note2,AI_omit_r2.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,428
note2,AI_omit_r2.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,428
note2,AI_omit_r2.txt,What condition has been confirmed by DEXA scans in the patient?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,428
note2,AI_omit_r2.txt,What surgical procedure was NOT mentioned in the patient's history?,Appendectomy,Appendectomy,Appendectomy,Appendectomy,432,428
note2,AI_omit_r2.txt,Which antibiotic is part of the patient's current treatment regimen?,Meropenem,Meropenem,Meropenem,Meropenem,432,428
note2,AI_omit_r2.txt,Which specialist services are involved in the patient's care?,Palliative care,Palliative care,Palliative care,Palliative care,432,428
note2,AI_omit_r3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,240
note2,AI_omit_r3.txt,Which surgical procedure was performed on the patient in September 2023?,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,240
note2,AI_omit_r3.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,240
note2,AI_omit_r3.txt,Which medications are part of the patient's current pain management regimen?,Fentanyl and Methadone,Fentanyl and Methadone,Fentanyl and Methadone,I don't know,432,240
note2,AI_omit_r3.txt,What imaging technique is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,240
note2,AI_omit_r3.txt,What type of care services are managing the patient's chronic pain?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,240
note2,AI_omit_r3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,240
note2,AI_omit_r3.txt,What is the patient's current antibiotic treatment for infections?,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,Meropenem and Vancomycin,432,240
note2,AI_omit_r3.txt,What surgical procedures has the patient undergone related to her urinary system?,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,Right nephrectomy and urinary diversion with ureterostomy and ileal conduit,I don't know,432,240
note2,AI_omit_r3.txt,What is the patient's follow-up care plan regarding potential malignancy?,Monitoring and evaluation of hepatic lesions,Monitoring and evaluation of hepatic lesions,Monitoring and evaluation of hepatic lesions,Monitoring and evaluation of hepatic lesions,432,240
note2,AI_omit_r3.txt,What type of lesions were revealed by imaging during the patient's recent ER admission?,Hepatic lesions and intraperitoneal collections,Hepatic lesions and intraperitoneal collections,Hepatic lesions and intraperitoneal collections,Hepatic lesions and intraperitoneal collections,432,240
note2,AI_omit_r3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),I don't know,432,240
note2,AI_omit_r3.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,240
note2,AI_omit_r3.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,240
note2,AI_omit_r3.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,240
note2,AI_omit_r3.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,240
note2,AI_omit_r3.txt,Which type of care is the patient transitioning to for ongoing management?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,240
note2,AI_omit_r3.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,I don't know,432,240
note2,AI_omit_r3.txt,"Which procedure was performed on September 21, 2023, to address bowel issues?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,240
note2,AI_omit_r3.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,240
note2,AI_omit_r3.txt,"What was the reason for the patient's hospital admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,240
note2,AI_omit_r3.txt,"Which procedure was performed on September 21, 2023?",End ileostomy,End ileostomy,End ileostomy,End ileostomy,432,240
note2,AI_omit_r3.txt,What is the primary purpose of the fentanyl patch prescribed at discharge?,Pain management,Pain management,Pain management,Pain management,432,240
note2,AI_omit_r3.txt,What imaging follow-up is recommended for the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,240
note2,AI_omit_r3.txt,Which medication was prescribed orally at discharge?,Suprax,Suprax,Suprax,Suprax,432,240
note2,AI_omit_r3.txt,What chronic condition does the patient have that affects the kidneys?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,240
note2,AI_omit_r3.txt,Which healthcare services are involved in the patient's follow-up care?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,240
note2,AI_omit_r3.txt,What is the patient's condition at discharge described as?,Complex with multisystem involvement,Complex with multisystem involvement,Complex with multisystem involvement,Complex with multisystem involvement,432,240
note2,AI_omit_r3.txt,What is a key component of the patient's discharge instructions?,Follow-up imaging for hepatic lesions,Follow-up imaging for hepatic lesions,Follow-up imaging for hepatic lesions,Follow-up imaging for hepatic lesions,432,240
note2,AI_omit_r3.txt,What is the significance of the pending results mentioned in the medical note?,They will assess potential malignancy of hepatic lesions,They will assess potential malignancy of hepatic lesions,They will assess potential malignancy of hepatic lesions,They will assess potential malignancy of hepatic lesions,432,240
note2,AI_omit_r3.txt,What type of care plan adaptation is mentioned in the additional notes?,Ongoing evaluation to improve quality of life,Ongoing evaluation to improve quality of life,Ongoing evaluation to improve quality of life,Ongoing evaluation to improve quality of life,432,240
note2,AI_omit_r3.txt,What is the primary focus of the patient's education and counseling at discharge?,Compliance with medication and follow-up appointments,Compliance with medication and follow-up appointments,Compliance with medication and follow-up appointments,Compliance with medication and follow-up appointments,432,240
note2,AI_omit_r3.txt,What condition was indicated by the severe abdominal pain during hospitalization?,Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,240
note2,AI_omit_r3.txt,What is the role of the multidisciplinary team in the patient's care?,To offer surgical consultations,To offer surgical consultations,To offer surgical consultations,To offer surgical consultations,432,240
note2,AI_omit_r3.txt,What is the patient's follow-up care plan focused on?,Monitoring potential malignancy of hepatic lesions,Monitoring potential malignancy of hepatic lesions,Monitoring potential malignancy of hepatic lesions,Monitoring potential malignancy of hepatic lesions,432,240
note2,AI_omit_r3.txt,What was the patient's condition related to the liver at discharge?,Hepatic lesions,Hepatic lesions,Hepatic lesions,Hepatic lesions,432,240
note2,AI_omit_r3.txt,What is the importance of the patient's compliance with follow-up appointments?,To effectively manage her complex condition,To effectively manage her complex condition,To effectively manage her complex condition,To effectively manage her complex condition,432,240
note2,AI_omit_r3.txt,"What was the reason for the patient's hospital admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,240
note2,AI_omit_r3.txt,"Which procedure was performed on September 21, 2023?",End ileostomy,End ileostomy,End ileostomy,End ileostomy,432,240
note2,AI_omit_r3.txt,What type of infections did the patient have at discharge?,Multidrug-resistant UTIs,Multidrug-resistant UTIs,Multidrug-resistant UTIs,Multidrug-resistant UTIs,432,240
note2,AI_omit_r4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,273
note2,AI_omit_r4.txt,"Which procedure was performed on September 21, 2023, to address bowel issues?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,273
note2,AI_omit_r4.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,273
note2,AI_omit_r4.txt,What surgical procedure has the patient undergone related to her urinary system?,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,I don't know,432,273
note2,AI_omit_r4.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,273
note2,AI_omit_r4.txt,What chronic condition is the patient being managed for by both pediatric and adult palliative care services?,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,Chronic visceral abdominal pain,432,273
note2,AI_omit_r4.txt,What is the patient's follow-up plan regarding potential malignancy?,Monitoring and PET/CT imaging,Monitoring and PET/CT imaging,Monitoring and PET/CT imaging,Monitoring and PET/CT imaging,432,273
note2,AI_omit_r4.txt,What type of surgical consultation is the patient undergoing for abdominal collections?,Multidisciplinary evaluation,Multidisciplinary evaluation,Multidisciplinary evaluation,I don't know,432,273
note2,AI_omit_r4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,273
note2,AI_omit_r4.txt,What renal condition is the patient experiencing?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,I don't know,432,273
note2,AI_omit_r4.txt,What type of imaging is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,273
note2,AI_omit_r4.txt,"What surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,273
note2,AI_omit_r4.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,273
note2,AI_omit_r4.txt,What type of collections were identified via imaging during the recent admissions?,Intraperitoneal collections,Intraperitoneal collections,Intraperitoneal collections,Intraperitoneal collections,432,273
note2,AI_omit_r4.txt,What is the patient's transition plan regarding care services?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,273
note2,AI_omit_r4.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,273
note2,AI_omit_r4.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,273
note2,AI_omit_r4.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,273
note2,AI_omit_r4.txt,What condition related to bone health has been confirmed in the patient?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,I don't know,432,273
note2,AI_omit_r4.txt,What is the primary focus of the patient's ongoing palliative care?,Management of chronic pain and improvement of quality of life,Management of chronic pain and improvement of quality of life,Management of chronic pain and improvement of quality of life,Management of chronic pain and improvement of quality of life,432,273
note2,AI_omit_r4.txt,"What was the primary reason for the patient's hospital admission on November 29, 2023?",Severe abdominal pain,Severe abdominal pain,Severe abdominal pain,Severe abdominal pain,432,273
note2,AI_omit_r4.txt,Which condition is associated with the patient's history of complex medical issues?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,273
note2,AI_omit_r4.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,273
note2,AI_omit_r4.txt,Which antibiotic is included in the patient's discharge medications?,Meropenem,Meropenem,Meropenem,Meropenem,432,273
note2,AI_omit_r4.txt,What is the purpose of the fentanyl patch in the patient's treatment plan?,To manage chronic pain,To manage chronic pain,To manage chronic pain,To manage chronic pain,432,273
note2,AI_omit_r4.txt,What follow-up care is recommended for the patient regarding potential malignancy?,Follow-up imaging with PET/CT,Follow-up imaging with PET/CT,Follow-up imaging with PET/CT,Follow-up imaging with PET/CT,432,273
note2,AI_omit_r4.txt,Which type of care is the patient transitioning to after discharge?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,273
note2,AI_omit_r4.txt,What condition is contributing to the patient's chronic renal impairment?,Recurrent multidrug-resistant urinary tract infections,Recurrent multidrug-resistant urinary tract infections,Recurrent multidrug-resistant urinary tract infections,Recurrent multidrug-resistant urinary tract infections,432,273
note2,AI_omit_r4.txt,What is the patient's condition at discharge described as?,Complex with ongoing infections and chronic pain,Complex with ongoing infections and chronic pain,Complex with ongoing infections and chronic pain,Complex with ongoing infections and chronic pain,432,273
note2,AI_omit_r4.txt,Which of the following procedures has the patient undergone multiple revisions for?,Urostomy and mass excision,Urostomy and mass excision,Urostomy and mass excision,Urostomy and mass excision,432,273
note2,AI_omit_r4.txt,What is the main focus of patient education and counseling at discharge?,"Infection signs, medication adherence, and pain management","Infection signs, medication adherence, and pain management","Infection signs, medication adherence, and pain management","Infection signs, medication adherence, and pain management",432,273
note2,AI_omit_r4.txt,What imaging study is pending for the evaluation of hepatic lesions?,PET/CT scan,PET/CT scan,PET/CT scan,PET/CT scan,432,273
note2,AI_omit_r4.txt,What is a key component of the patient's discharge instructions regarding infection?,Monitor for signs of infection,Monitor for signs of infection,Monitor for signs of infection,Monitor for signs of infection,432,273
note2,AI_omit_r4.txt,What is the role of the healthcare providers managing the patient?,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,Pediatric and adult palliative care services,432,273
note2,AI_omit_r4.txt,Which condition is NOT listed as a discharge diagnosis for the patient?,Acute myocardial infarction,Acute myocardial infarction,Acute myocardial infarction,Acute myocardial infarction,432,273
note2,AI_omit_r4.txt,What is the patient's discharge medication regimen for infection management?,Oral Suprax and intravenous Meropenem and Vancomycin,Oral Suprax and intravenous Meropenem and Vancomycin,Oral Suprax and intravenous Meropenem and Vancomycin,Oral Suprax and intravenous Meropenem and Vancomycin,432,273
note2,AI_omit_r4.txt,What is the patient's condition regarding surgical options?,Limited surgical options,Limited surgical options,Limited surgical options,Limited surgical options,432,273
note2,AI_omit_r4.txt,What type of follow-up care is emphasized for the patient's hepatic lesions?,Ongoing monitoring with imaging,Ongoing monitoring with imaging,Ongoing monitoring with imaging,Ongoing monitoring with imaging,432,273
note2,AI_omit_r4.txt,"What was the reason for the patient's hospital admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,273
note2,AI_omit_r4.txt,Which condition is part of the patient's complex medical history?,Malignant peripheral nerve sheath tumor,Malignant peripheral nerve sheath tumor,Malignant peripheral nerve sheath tumor,Malignant peripheral nerve sheath tumor,432,273
note2,AI_omit_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,349
note2,AI_omit_r5.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,349
note2,AI_omit_r5.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,349
note2,AI_omit_r5.txt,What imaging is planned for evaluating the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,349
note2,AI_omit_r5.txt,What condition has been confirmed by DEXA scans in the patient?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,I don't know,432,349
note2,AI_omit_r5.txt,What type of care is the patient receiving for chronic pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,349
note2,AI_omit_r5.txt,What surgical procedure has the patient undergone related to her urinary system?,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,432,349
note2,AI_omit_r5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,349
note2,AI_omit_r5.txt,What is the patient's follow-up care plan regarding potential malignancy?,Monitoring and imaging,Monitoring and imaging,Monitoring and imaging,Monitoring and imaging,432,349
note2,AI_omit_r5.txt,What is the patient's history of postoperative treatment for MPNST?,External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),432,349
note2,AI_omit_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,349
note2,AI_omit_r5.txt,"Which treatment was completed on December 16, 2018, for the patient's MPNST?",External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),External beam radiotherapy (EBRT),432,349
note2,AI_omit_r5.txt,What chronic renal condition does the patient have?,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,Chronic renal impairment,432,349
note2,AI_omit_r5.txt,What imaging modality is planned for follow-up of the patient's hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,349
note2,AI_omit_r5.txt,"What surgical procedure did the patient undergo on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,349
note2,AI_omit_r5.txt,What is the primary goal of the patient's current palliative care?,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,Manage chronic pain and improve quality of life,432,349
note2,AI_omit_r5.txt,What is the patient's follow-up plan regarding potential malignancy?,Monitoring with PET/CT,Monitoring with PET/CT,Monitoring with PET/CT,Monitoring with PET/CT,432,349
note2,AI_omit_r5.txt,Which department is the patient transitioning to for continued care?,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,Adult oncology and palliative care,432,349
note2,AI_omit_r5.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,349
note2,AI_omit_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,349
note2,AI_omit_r5.txt,Which surgical procedure did the patient undergo in September 2023?,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,349
note2,AI_omit_r5.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,349
note2,AI_omit_r5.txt,Which antibiotic is NOT part of the patient's current treatment plan?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,349
note2,AI_omit_r5.txt,What imaging modality is planned for follow-up of the hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,349
note2,AI_omit_r5.txt,What chronic condition is the patient experiencing that requires ongoing management?,Chronic pain,Chronic pain,Chronic pain,Chronic pain,432,349
note2,AI_omit_r5.txt,What surgical procedure did the patient undergo related to her urinary system?,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,432,349
note2,AI_omit_r5.txt,What complication was identified via imaging in November 2023?,Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,349
note2,AI_omit_r5.txt,What condition was treated with postoperative external beam radiotherapy in 2018?,Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),Malignant peripheral nerve sheath tumor (MPNST),432,349
note2,AI_omit_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,349
note2,AI_omit_r5.txt,What postoperative treatment did the patient receive after tumor excision in 2018?,External Beam Radiotherapy (EBRT),External Beam Radiotherapy (EBRT),External Beam Radiotherapy (EBRT),External Beam Radiotherapy (EBRT),432,349
note2,AI_omit_r5.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,349
note2,AI_omit_r5.txt,What chronic renal condition does the patient have?,Chronic renal impairment with a history of resolving acute kidney injury (AKI),Chronic renal impairment with a history of resolving acute kidney injury (AKI),Chronic renal impairment with a history of resolving acute kidney injury (AKI),Chronic renal impairment with a history of resolving acute kidney injury (AKI),432,349
note2,AI_omit_r5.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,349
note2,AI_omit_r5.txt,What condition has caused the patient to have a single functioning kidney?,Right nephrectomy,Right nephrectomy,Right nephrectomy,Right nephrectomy,432,349
note2,AI_omit_r5.txt,"What complication was suggested by imaging on November 29, 2023?",Bowel obstruction,Bowel obstruction,Bowel obstruction,Bowel obstruction,432,349
note2,AI_omit_r5.txt,What type of infections are confirmed via imaging?,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,Intra-abdominal infections,432,349
note2,AI_omit_r5.txt,What is the patient's planned follow-up care for infection management?,Continued intravenous antibiotics and follow-up imaging,Continued intravenous antibiotics and follow-up imaging,Continued intravenous antibiotics and follow-up imaging,Continued intravenous antibiotics and follow-up imaging,432,349
note2,AI_omit_r5.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,349
note2,AI_omit_r5.txt,What surgical procedure did the patient undergo in September 2023?,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,349
note2,AI_omit_r5.txt,Which antibiotic is NOT part of the patient's current intravenous treatment?,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,Ciprofloxacin,432,349
note2,original.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,548
note2,original.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,548
note2,original.txt,What is the current renal condition of the patient?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,548
note2,original.txt,What imaging modality is planned for follow-up of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,548
note2,original.txt,Which medication is part of the patient's current antibiotic regimen?,Meropenem,Meropenem,Meropenem,Meropenem,432,548
note2,original.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,548
note2,original.txt,What surgical procedure has the patient undergone related to the urinary system?,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,Right nephrectomy and urinary diversion,432,548
note2,original.txt,What type of care is the patient receiving for her chronic pain?,Palliative care,Palliative care,Palliative care,Palliative care,432,548
note2,original.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,548
note2,original.txt,"What surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,Exploratory laparotomy with adhesiolysis and small bowel resection,432,548
note2,original.txt,What imaging is planned for further evaluation of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,548
note2,original.txt,What is the current antibiotic treatment for the patient's infections?,Meropenem and Vancomycin with oral Suprax,Meropenem and Vancomycin with oral Suprax,Meropenem and Vancomycin with oral Suprax,Meropenem and Vancomycin with oral Suprax,432,548
note2,original.txt,What type of surgical consultation is planned for the patient?,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,Multidisciplinary evaluation for abdominal collections,432,548
note2,original.txt,What is the patient's current status regarding palliative care?,Managed by pediatric and adult palliative care services,Managed by pediatric and adult palliative care services,Managed by pediatric and adult palliative care services,Managed by pediatric and adult palliative care services,432,548
note2,original.txt,What is the patient's follow-up care plan regarding oncology?,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,Transition to adult oncology and palliative care,432,548
note2,original.txt,"What was the reason for the patient's ER admission on January 24, 2024?",Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,Infected abdominal wound and pain,432,548
note2,original.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),Neurofibromatosis Type 1 (NF1),432,548
note2,original.txt,"Which surgical procedure was performed on September 21, 2023?",Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,Exploratory laparotomy with adhesiolysis,432,548
note2,original.txt,What imaging is planned for further evaluation of hepatic lesions?,PET/CT,PET/CT,PET/CT,PET/CT,432,548
note2,original.txt,Which condition has the patient been non-compliant with treatment for?,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,Osteopenia and Osteoporosis,432,548
note2,original.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,548
note2,original.txt,"Which surgical procedure was performed on September 21, 2023?",Exploration laparotomy with adhesiolysis,Exploration laparotomy with adhesiolysis,Exploration laparotomy with adhesiolysis,Exploration laparotomy with adhesiolysis,432,548
note2,original.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,548
note2,original.txt,What imaging finding raised concerns for bowel obstruction in November 2023?,Incomplete passage of contrast beyond 10 cm from the ileostomy,Incomplete passage of contrast beyond 10 cm from the ileostomy,Incomplete passage of contrast beyond 10 cm from the ileostomy,Incomplete passage of contrast beyond 10 cm from the ileostomy,432,548
note2,original.txt,What condition related to bone density does the patient have?,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,Osteopenia and osteoporosis,432,548
note2,original.txt,What type of follow-up imaging is planned for the hepatic lesions?,PETCT,PETCT,PETCT,PETCT,432,548
note2,original.txt,What is the main focus of the patient's ongoing palliative care?,Management of chronic pain and quality of life,Management of chronic pain and quality of life,Management of chronic pain and quality of life,Management of chronic pain and quality of life,432,548
note2,original.txt,What is the main reason for the patient's transition to adult oncology and palliative care services?,Need for specialized care in managing complex issues,Need for specialized care in managing complex issues,Need for specialized care in managing complex issues,Need for specialized care in managing complex issues,432,548
note2,original.txt,What is the patient's current renal condition?,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,Single left kidney with progressive hydronephrosis,432,548
note2,original.txt,"What surgical procedure was performed on September 21, 2023?",Small bowel resection and end ileostomy,Small bowel resection and end ileostomy,Small bowel resection and end ileostomy,Small bowel resection and end ileostomy,432,548
note2,original.txt,"What imaging was aborted due to severe abdominal pain on November 29, 2023?",Distal loop fluoroscopy,Distal loop fluoroscopy,Distal loop fluoroscopy,Distal loop fluoroscopy,432,548
note2,original.txt,What type of follow-up imaging is planned for the hepatic lesions?,PET-CT,PET-CT,PET-CT,PET-CT,432,548
note2,original.txt,What was the result of the patient's 2021 lumbar T-score?,-2.2,-2.2,I don't know,-2.2,432,548
note2,original.txt,What type of infection was confirmed via imaging in January 2024?,Intra-abdominal infection,Intra-abdominal infection,Intra-abdominal infection,Intra-abdominal infection,432,548
note2,original.txt,What is the patient's current status regarding adult oncology and palliative care services?,Transition to services,Transition to services,Transition to services,Transition to services,432,548
note2,original.txt,What is the primary genetic condition affecting the patient?,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,Neurofibromatosis Type 1,432,548
note2,original.txt,"What surgical procedure was performed on September 21, 2023?",Laparotomy with adhesiolysis and small bowel resection,Laparotomy with adhesiolysis and small bowel resection,Laparotomy with adhesiolysis and small bowel resection,Laparotomy with adhesiolysis and small bowel resection,432,548
note2,original.txt,"What imaging finding was noted on January 24, 2024?",Three intraperitoneal collections,Three intraperitoneal collections,Three intraperitoneal collections,Three intraperitoneal collections,432,548
note2,original.txt,What is the planned follow-up imaging for hepatic lesions?,PETCT,PETCT,PETCT,PETCT,432,548
note2,original.txt,What is the patient's discharge plan regarding oncology care?,Transition to adult oncology and palliative care services,Transition to adult oncology and palliative care services,Transition to adult oncology and palliative care services,Transition to adult oncology and palliative care services,432,548
